• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

设计药物:从药物化学角度来看。

Designer drugs: a medicinal chemistry perspective.

机构信息

Center for Organic and Medicinal Chemistry, Research Triangle Institute, Research Triangle Park, North Carolina 27709-2194, USA.

出版信息

Ann N Y Acad Sci. 2012 Feb;1248:18-38. doi: 10.1111/j.1749-6632.2011.06199.x. Epub 2011 Nov 17.

DOI:10.1111/j.1749-6632.2011.06199.x
PMID:22092008
Abstract

There are numerous medicinal chemistry reports in the literature describing the pharmacological properties of thousands of narcotics, stimulants, hallucinogens, sedative-hypnotic drugs, cannabinoids, and other psychoactive substances as well as synthetic methods for their preparations. This information, while essential for the advancement of science, has been used by clandestine chemists to manufacture and market an endless variety of analogs of so-called designer drugs. In this review, we describe how clandestine chemists used the principles of medicinal chemistry to design molecules, referred to as designer drugs, that elicit the effects of opioids, amphetamine and analogs, cannabinoids, and phencyclidine analogs while circumventing the law.

摘要

文献中有大量的药物化学报告,描述了数千种麻醉品、兴奋剂、致幻剂、镇静催眠药、大麻素和其他精神活性物质的药理学特性,以及它们的制备方法。这些信息对于科学的发展是必不可少的,但却被秘密化学家用来制造和销售所谓的“设计药物”的各种类似物。在这篇综述中,我们描述了秘密化学家如何利用药物化学原理来设计分子,这些分子被称为“设计药物”,它们能引发阿片类药物、苯丙胺及其类似物、大麻素和苯环己哌啶类似物的作用,同时规避法律。

相似文献

1
Designer drugs: a medicinal chemistry perspective.设计药物:从药物化学角度来看。
Ann N Y Acad Sci. 2012 Feb;1248:18-38. doi: 10.1111/j.1749-6632.2011.06199.x. Epub 2011 Nov 17.
2
Chemistry, pharmacology, and metabolism of emerging drugs of abuse.新兴滥用药物的化学、药理学和代谢。
Ther Drug Monit. 2010 Oct;32(5):544-9. doi: 10.1097/FTD.0b013e3181eea318.
3
Emergence and properties of spice and bath salts: a medicinal chemistry perspective.“香料”和“浴盐”的出现及其特性:从药物化学角度看。
Life Sci. 2014 Feb 27;97(1):9-19. doi: 10.1016/j.lfs.2013.09.026. Epub 2013 Oct 7.
4
Methamphetamine: history, pathophysiology, adverse health effects, current trends, and hazards associated with the clandestine manufacture of methamphetamine.甲基苯丙胺:历史、病理生理学、对健康的不良影响、当前趋势以及与甲基苯丙胺秘密制造相关的危害。
Dis Mon. 2012 Feb;58(2):38-89. doi: 10.1016/j.disamonth.2011.09.004.
5
Analysis of first and second generation legal highs for synthetic cannabinoids and synthetic stimulants by ultra-performance liquid chromatography and time of flight mass spectrometry.超高效液相色谱-飞行时间质谱法分析第一代和第二代合成大麻素及合成兴奋剂
J Anal Toxicol. 2012 Jul;36(6):360-71. doi: 10.1093/jat/bks047. Epub 2012 May 14.
6
Designer drugs: a medicinal chemistry perspective (II).设计药物:药物化学视角(二)。
Ann N Y Acad Sci. 2021 Apr;1489(1):48-77. doi: 10.1111/nyas.14349. Epub 2020 May 12.
7
Doors of deception: the diaspora of designer drugs.
Drug Test Anal. 2011 Sep;3(9):527-31. doi: 10.1002/dta.302.
8
Synthetic cathinones: chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as "bath salts" or "plant food".合成卡西酮:作为“浴盐”或“植物肥料”出售的一类新的设计类滥用药物的化学、药理学和毒理学。
Toxicol Lett. 2012 Jun 1;211(2):144-9. doi: 10.1016/j.toxlet.2012.03.009. Epub 2012 Mar 21.
9
[Synthetic cannabinoids--the new "legal high" drugs].[合成大麻素——新型“合法兴奋剂”药物]
Harefuah. 2011 Dec;150(12):884-7, 937.
10
Top 10 Facts You Need to Know About Synthetic Cannabinoids: Not So Nice Spice.关于合成大麻素你需要了解的十大事实:并非那么美妙的香料。
Am J Med. 2016 Mar;129(3):240-4.e1. doi: 10.1016/j.amjmed.2015.10.008. Epub 2015 Oct 30.

引用本文的文献

1
Determination of Arylcyclohexylamines in Biological Specimens: Sensors and Sample Pre-Treatment Approaches.生物样本中芳基环己胺的测定:传感器与样品预处理方法
Micromachines (Basel). 2024 Jul 30;15(8):984. doi: 10.3390/mi15080984.
2
Opioid-Based Haptens: Development of Immunotherapy.基于阿片类药物的半抗原:免疫疗法的发展。
Int J Mol Sci. 2024 Jul 16;25(14):7781. doi: 10.3390/ijms25147781.
3
The endocannabinoid system and breathing.内源性大麻素系统与呼吸。
Front Neurosci. 2023 Apr 18;17:1126004. doi: 10.3389/fnins.2023.1126004. eCollection 2023.
4
An Update on the Implications of New Psychoactive Substances in Public Health.新精神活性物质对公共健康影响的最新研究进展。
Int J Environ Res Public Health. 2022 Apr 17;19(8):4869. doi: 10.3390/ijerph19084869.
5
Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017-2020: A Review.报告称,2017 年至 2020 年与新型精神活性物质使用相关的不良事件:一项综述。
J Anal Toxicol. 2022 Jul 14;46(6):e116-e185. doi: 10.1093/jat/bkac023.
6
Amphetamine-type stimulants (ATS) drug classification using shallow one-dimensional convolutional neural network.使用浅层一维卷积神经网络对苯丙胺类兴奋剂(ATS)进行药物分类。
Mol Divers. 2022 Jun;26(3):1609-1619. doi: 10.1007/s11030-021-10289-1. Epub 2021 Aug 2.
7
Khat Chewing Practice and Associated Factors among Medical Students in Gondar Town, Ethiopia, 2019.2019年埃塞俄比亚贡德尔镇医科学生的恰特草咀嚼行为及相关因素
Subst Abuse. 2021 Mar 2;15:1178221821999079. doi: 10.1177/1178221821999079. eCollection 2021.
8
Discovery of novel diarylamides as orally active diuretics targeting urea transporters.发现新型二芳基酰胺作为靶向尿素转运蛋白的口服活性利尿剂。
Acta Pharm Sin B. 2021 Jan;11(1):181-202. doi: 10.1016/j.apsb.2020.06.001. Epub 2020 Jun 14.
9
Likelihood of depressive symptoms in US older adults by prescribed opioid potency: National Health and Nutrition Examination Survey 2005-2013.美国老年人使用阿片类药物的效力与抑郁症状发生的可能性:2005-2013 年全国健康和营养调查。
Int J Geriatr Psychiatry. 2019 Oct;34(10):1481-1489. doi: 10.1002/gps.5157. Epub 2019 Jun 11.
10
Molecular dynamics of fentanyl bound to μ-opioid receptor.芬太尼与 μ 阿片受体结合的分子动力学。
J Mol Model. 2019 May 3;25(5):144. doi: 10.1007/s00894-019-3999-2.